Pilot supports real-world endpoints as surrogates for OS

Friends of Cancer Research released data Tuesday that support the use of real-world evidence (RWE) outcomes -- including real-world progression-free survival (rwPFS) -- as surrogate endpoints for overall survival to evaluate a treatment's long-term effects.

In the pilot program, a working group led by the non-profit Friends evaluated electronic health records (EHR) and

Read the full 520 word article

User Sign In